EICHOR
● Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Condition: Atopic Dermatitis · Eczema, Atopic · Sponsor: Pfizer
About this study
The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin. The study is seeking participants who: 1. Are 18 to 64 years of age; 2. Were confirmed to have AD at least 6 months ago; 3. Do not have a suitable prescribed medicine for AD; 4. Are considered by their doctors to have moderate to severe AD. The study has two stages (Stage 1 and Stage 2). In both stages, eligible participants will take either PF-08049820 or placebo as tablets by mouth daily for 12 weeks. A placebo does not have any medicine in it but looks just like the medicine being studied. Participants will visit the clinic on Day 1, Weeks 1, 2, 4, 6, 8 and 12. They will have a follow-up visit at Week 16. During this time, the participant's health and skin condition will be checked. They will have blood and urine tests. They will also have to answer questions about their health, skin condition, and how much their skin condition affects their lives. The experiences of participants receiving the study medicine will be compared to those receiving placebo. This will help to understand if PF-08049820 is safe and effective.
This description comes directly from the study's public registry record.
Talk to the study team
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
Locations (20)
| Marvel Clinical Research | Huntington Beach, California, United States | Recruiting |
| Metropolis Dermatology - DTLA | Los Angeles, California, United States | Not Yet Recruiting |
| Northridge Clinical Trials | Northridge, California, United States | Recruiting |
| Clinical Science Institute | Santa Monica, California, United States | Active Not Recruiting |
| Gsi Clinical Research | Margate, Florida, United States | Recruiting |
| Skin Research of South Florida | Miami, Florida, United States | Active Not Recruiting |
| Montefiore - Jacobi Dermatology Clinic | The Bronx, New York, United States | Recruiting |
| Montefiore - Clinical Research Center | The Bronx, New York, United States | Recruiting |
| Montefiore - Greene Medical Arts Pavillion | The Bronx, New York, United States | Recruiting |
| Montefiore - The Dermatology Center | The Bronx, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| UPMC Department of Dermatology | Pittsburgh, Pennsylvania, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07216027